Post-COVID-19 Syndrome Triples Use of Further Health Care Services

TUESDAY, Dec. 13, 2022 (HealthDay News) -- People with long COVID are more likely to use health care services following acute infection, according to a study published online Nov. 30 in PLOS Global Public Health.
Maciej Debski, M.D., Ph.D., from the University of East Anglia in the United Kingdom, and colleagues surveyed patients with confirmed COVID-19 infection by real-time polymerase chain reaction (as of Dec. 6, 2020) to understand the burden and predictors for post-COVID-19 syndrome. The analysis included 1,487 responses.
The researchers found that post-COVID-19 symptoms were reported by 52.1 percent of respondents. Male sex was a protective factor (relative risk [RR], 0.748). Higher body mass index (BMI) was associated with a greater risk for developing post-COVID-19 symptoms (RR, 1.031 for 1 kg/m2). One-quarter of respondents (25.4 percent) used further health services after their index COVID-19 infection, of whom 73.2 percent reported post-COVID-19 symptoms. There was a negative association observed between male sex and use of further health services (RR, 0.618), while BMI was positively associated with use (RR, 1.027). Post-COVID-19 symptoms more than tripled the probability of using health services (RR, 3.280).
"We hope that our work will help policymakers plan local services and also inform the wider public of the scale of the long COVID pandemic," a coauthor said in a statement.
Related Posts
AHA News: Este procedimiento de extracción de coágulos parece ser seguro en pacientes embarazadas que han padecido un ataque cerebral
LUNES, 20 de septiembre de 2021 (American Heart Association News) -- Extraer...
¿Debe ponerse una dosis de refuerzo de una vacuna contra la COVID?
LUNES, 4 de abril de 2022 (HealthDay News) -- Ahora que muchos estadounidenses...
Jane Fonda Says Her Lymphoma Is in Remission
FRIDAY, Dec. 16, 2022 (HealthDay News) – Actress and two-time Academy Award...
FDA Postpones Decision on Pfizer COVID-19 Vaccine for Under 5s
FRIDAY, Feb. 11, 2022 (HealthDay News) -- The U.S. Food and Drug Administration...
